{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-000483","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2024-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.121863+00:00","generated_at":"2026-06-07T04:35:40.118305+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SANUWAVE Health closes $1.9M convertible note financing with 93M warrants","bullets":["Issued $1.9M principal 15% convertible notes, conversion price $0.04; net proceeds $1.8M.","Issued 46.5M warrants at $0.067 and 46.5M at $0.04, each 5-yr term, subject to anti-dilution adjustments.","Subordination agreement with NH Expansion Credit Fund Holdings LP subordinates notes to prior lender.","Exchange letter agreements with purchasers for conversion into common stock prior to planned SEPA merger.","Waived reverse stock split, share reserve, and registration obligations through Dec 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-000483","json":"https://secwatch.observer/filing/0001140361-24-000483.json","markdown":"https://secwatch.observer/filing/0001140361-24-000483.md","text":"https://secwatch.observer/filing/0001140361-24-000483.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124000483/0001140361-24-000483-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124000483/ef20017967_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:35:40.118305+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"48e1f1150cb8fb773e49bb6208d28389bf4c8558","claim":"SANUWAVE Health, Inc. incurred convertible notes of aggregate principal amount of approximately $1.9 million with Purchasers at fifteen percent (15%) per annum maturing maturity date.","evidence_excerpt":"On December 30, 2023, the Company issued Notes to the Purchasers in an aggregate principal amount of $1.9 million. Pursuant to the Notes, the Company promised to pay each Purchaser, its designee or registered assigns (the \"Holder\") in cash and/or in shares of common stock, at a conversion price of $0.04 (the \"Conversion Price\"), the principal amount (subject to reduction pursuant to the terms of the Note, the \"Principal\") as may be advanced in disbursements (each, a \"Disbursement\" and together, the \"Disbursements,\" with total principal of outstanding Disbursements equaling Principal), and to pay interest at a rate of fifteen percent (15%) per annum (\"Interest\") on any outstanding Principal at the applicable Interest rate from the date of the Notes until the Notes are accelerated, converted, redeemed or otherwise.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124000483/0001140361-24-000483-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"aggregate principal amount of approximately $1.9 million"},{"label":"Counterparty","value":"Purchasers"},{"label":"Rate","value":"fifteen percent (15%) per annum"},{"label":"Maturity","value":"maturity date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"4e301cdf667454f3b3b3256119206331d7530c02","claim":"SANUWAVE Health, Inc. entered into Securities Purchase Agreement with the Purchasers valued at approximately $1.9 million (effective 2023-12-30).","evidence_excerpt":"On December 30, 2023, SANUWAVE Health, Inc. (“SANUWAVE” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”), with the purchasers identified on the signature pages thereto (the “Purchasers”) for the sale by the Company in a private placement (the “Private Placement”) of (i) the Company’s future advance convertible promissory notes in an aggregate principal amount of approximately $1.9 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124000483/0001140361-24-000483-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the Purchasers"},{"label":"Value","value":"approximately $1.9 million"},{"label":"Effective","value":"2023-12-30"}],"fact_type":"material_agreement"},{"claim_id":"a40f6d03924c11caeb0b62f304b89659ed44f71e","claim":"SANUWAVE Health, Inc. entered into Registration Rights Agreement with the Purchasers (effective 2023-12-30).","evidence_excerpt":"In connection with the Purchase Agreement, the Company entered into a registration rights agreement with the Purchasers on December 30, 2023 (the “Registration Rights Agreement”),","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124000483/0001140361-24-000483-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"the Purchasers"},{"label":"Effective","value":"2023-12-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}